相关实验视频
Updated: Jan 17, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
9.0K
激素治疗与急性前列腺切除术后的救援放射治疗:系统性审查和元分析
Reyhaneh Bayani1,2,3, Kasra Kolahdouzan1,2, Sepehr Nayebirad4
1Department of Radiation Oncology, Imam Khomeini Hospital Complex, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
The Prostate
|September 23, 2025
概括
在前列腺切除术后,将激素治疗添加到放射治疗中,可显著改善前列腺癌患者的生存结果,延迟疾病的进展. 这种方法提高了无转移和无进展的生存率.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 救援放射治疗 (RT) 是前列腺癌复发后的基本前列腺切除术 (RP) 的标准.
- 与RT同时进行激素治疗的作用受到争议.
- 这项研究系统地审查了带有或没有激素治疗对生存的影响的RT.
研究的目的:
- 为了评估添加激素治疗到辅助剂或救援RT的疗效.
- 评估对整体生存 (OS),无转移生存 (MFS) 和无进展生存 (PFS) 的影响.
主要方法:
- 随机二期或三期试验的系统审查和元分析.
- 搜索了PubMed,Scopus,科学网和临床试验注册表.
- 使用逆方差方法对危险比率 (HR) 和95%置信区间 (CI) 进行随机效应元分析.
主要成果:
- 包括四项具有偏差风险较低的试验.
- 汇总HR青的激素治疗:OS 0.85 (95% CI:0.72-0.99),MFS 0.82 (95% CI:0.70-0.96),PFS 0.58 (95% CI:0.51-0.66). 在这些患者中,最常见的症状是:
- 敏感性分析不包括一个试验删除了OS显著性.
结论:
- 激素治疗与前列腺切除术后的RT相结合显著改善了OS,MFS和PFS.
- 虽然OS的益处不那么强大,但激素治疗在延缓前列腺癌进展方面发挥着关键作用.
- 研究结果支持激素治疗在治疗复发性前列腺癌后的治疗中的作用.
相关概念视频
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:21Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650